Study guide

3.4 Medical History Components for MTM

PTCB Medication Therapy Management Certificate Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts & Format 1.2 Eligibility, Application & Testing 1.3 Pharmacy Technician Role in MTM 1.4 Domain Weights & Study Strategy

2 Chapter 2: Medication Product Knowledge

2.1 Strengths, Doses, and Drug Classes 2.2 Dosage Forms, Routes, and Administration Instructions 2.3 Storage, Special Handling, and Duration of Therapy 2.4 Interchangeable Classes and Forms for Cost Savings

3 Chapter 3: Terminology & History Collection

3.1 Patient-Friendly Medical Terminology 3.2 Medication Allergy vs Medication Intolerance 3.3 Adherence Definitions in Medication History 3.4 Medical History Components for MTM

4 Chapter 4: Medication-Related Problems & Labs

4.1 Common Medication-Related Problems Overview 4.2 Side Effects, Adverse Drug Reactions & Allergies in MTM 4.3 Nonadherence, Affordability Barriers & Gaps in Therapy 4.4 Lab Measures & Related Medical Terms in MTM

5 Chapter 5: Adherence Calculations

5.1 Days’ Supply, Quantity, and Dose 5.2 Proportion of Days Covered (PDC) 5.3 PQA Threshold & Star Ratings Adherence Measures

6 Chapter 6: Documentation Accuracy Reviews

6.1 Personal Medication Record (PMR) Accuracy Review 6.2 MAP and CMR Documentation Accuracy 6.3 MTM Billing Fields Accuracy Checks

7 Chapter 7: Prescribing Errors & Therapy Conflicts

7.1 Types of Prescribing Errors 7.2 Inappropriate Prescribing & Duplicate Therapy 7.3 Drug Interactions & Conflicting Therapies 7.4 Impact of Prescribing Errors & Medication Problems

8 Chapter 8: High-Risk Medications in Older Adults

8.1 2023 AGS Beers Criteria: High-Risk Medications in Older Adults 8.2 STOPP/START Concepts & Anticholinergic Burden in MTM Screening 8.3 High-Alert & Narrow Therapeutic Index Awareness for MTM Tech Support

9 Chapter 9: MTM Core Elements

9.1 Purpose of MTM & Five Core Elements 9.2 Medication Therapy Review (MTR) 9.3 Personal Medication Record (PMR) 9.4 Medication-Related Action Plan (MAP)

10 Chapter 10: Intervention, Documentation & CMS Rules

10.1 Intervention, Referral & Follow-Up 10.2 MTM Documentation Standards 10.3 CMS Part D MTM Targeting Requirements

11 Chapter 11: CMR, TMR, Billing & Workflow

11.1 Comprehensive Medication Review (CMR) 11.2 Targeted Medication Review (TMR) 11.3 CPT Billing Codes for MTM (99605 / 99606 / 99607) 11.4 Workflow Prioritization, Stages & Timelines

3.4 Medical History Components for MTM

Key Takeaways Explain This Topic AI

MTM medication history includes medical conditions, social history, and immunizations—not only the drug list

Condition lists (for example AFib, T2DM, HFrEF, CKD) explain indication, organ function limits, and monitoring needs

Social history covers tobacco, alcohol, and recreational drug use plus other lifestyle factors that change medication risk and adherence

Immunization gaps (influenza, pneumococcal, zoster, Tdap/Td, RSV per ACIP) are screening finds technicians can flag for pharmacist follow-up

  • Accurate condition and social details prevent incomplete PMRs and missed medication-related problems
  • Last updated: August 2026

Medical History Components for MTM

Quick Answer: For MTM medication history, collect medical conditions , social history , and immunizations in addition to medications and allergies. These pieces explain indications, uncover risks, and identify preventive gaps for pharmacist review.

A medication list without context is a shopping list. Domain 1 expects technicians to understand medical-history key terms used while building a Personal Medication Record (PMR) and preparing Comprehensive Medication Review (CMR) or Targeted Medication Review (TMR) materials.

Medical Conditions (Problem List)

Medical conditions are current and relevant past diagnoses that shape drug therapy: what needs treatment, what organ systems limit drug choice, and what monitoring is required.

Common chronic conditions in MTM populations include:

  • Hypertension (high blood pressure)
  • Type 2 diabetes mellitus (T2DM)
  • Dyslipidemia (high cholesterol / abnormal lipids)
  • Atrial fibrillation (AFib)
  • Heart failure, including HFrEF (reduced pumping strength)
  • Chronic kidney disease (CKD) by stage when known
  • COPD or asthma
  • Osteoporosis, depression, chronic pain, and GERD

When a draft PMR shows abbreviations such as "AFib, T2DM, HFrEF, CKD3," expand them for patient materials and keep precise terms for clinical use:

  • Abbreviation Condition meaning
  • AFib Atrial fibrillation
  • T2DM Type 2 diabetes mellitus
  • HFrEF Heart failure with reduced ejection fraction
  • CKD3 Stage 3 chronic kidney disease

Why conditions matter to technicians:

Indication check — Every chronic drug should map to a condition (or a stated preventive indication).

Safety flags — CKD affects renally cleared drugs; heart failure affects certain diabetes drugs and NSAIDs; AFib often pairs with anticoagulants.

Duplicate therapy clues — Two drugs for the same condition may be intentional combination therapy or an error.

Lab context — A1C belongs with diabetes; INR with warfarin; potassium and kidney labs with ACE inhibitors/ARBs and diuretics.

Technician Script — Confirming Conditions

Tech: "Your chart lists type 2 diabetes, high blood pressure, and stage 3 kidney disease. Does that still match what your doctors have told you?" Patient: "Yes, and they also said I have AFib now." Tech: "Thank you—I'll add atrial fibrillation—an irregular heartbeat—to the condition list for the pharmacist's review, and we'll make sure your blood thinner and other meds are on the PMR."

Do not diagnose. Confirm, clarify wording, and escalate discrepancies (patient denies a listed condition, or reports a new one not on file).

Social History

Social history captures lifestyle and substance-use factors that interact with medications, adherence, and safety. In MTM screening, prioritize:

Tobacco (cigarettes, vaping, smokeless) — affects cardiovascular risk, some drug metabolism discussions, and counseling priorities

  • Alcohol — interacts with sedatives, anticoagulants, metformin risk discussions, and adherence patterns
  • Recreational / non-prescribed drug use — including cannabis or opioids not on the legal prescription profile

Related practical factors often collected alongside social history: living situation, caregiver support, and whether the patient manages meds independently

Social history is not the same as:

  • The allergy list
  • The current prescription list
  • Immunization history (related preventive domain, separate section of the interview)
  • Social history element Why it matters in MTM
  • Tobacco use Cardiovascular risk; cessation opportunities; some therapy considerations
  • Alcohol use Interaction and safety risks; may explain dizziness or adherence gaps
  • Recreational drugs Hidden CNS depression risk, adherence issues, incomplete PMR
  • Caregiver / living support Who should receive MAP teaching; pill-box feasibility
  • Technician Script — Sensitive but Direct

Tech: "To keep your medication review safe, I ask everyone about tobacco, alcohol, and any other substances. Do you currently smoke or use tobacco?" Patient: "A few cigarettes a week." Tech: "Thanks. Any regular alcohol use—about how many drinks per week?" Patient: "Maybe three or four on weekends." Tech: "I'll document that for the pharmacist. It helps when reviewing blood thinners, diabetes meds, and anything that causes drowsiness."

Normalize the questions. Judgment reduces honesty; honesty reduces preventable harm.

Immunizations

Immunization history is part of medical history for MTM because gaps are common preventive medication-related opportunities. Technicians screen and refer; pharmacists (or other authorized vaccinators per state law) decide and administer.

Adult immunizations frequently relevant during MTM screening (follow current CDC ACIP schedules; details change over time):

  • Influenza — routinely recommended annually for adults (and broadly for ages 6 months and older)
  • COVID-19 — per current ACIP adult recommendations
  • Pneumococcal vaccines — especially important in older adults and high-risk conditions
  • Recombinant zoster vaccine (Shingrix) — routinely for adults 50 years and older (2-dose series)
  • Tdap / Td — boosters per schedule (often every 10 years for Td/Tdap as indicated)

RSV — recommended for older adults per current age/risk criteria (for example, broader recommendation at older ages and risk-based in younger older-adult groups)

During history:

Ask which vaccines the patient recalls and approximate dates.

Check available immunization registry or pharmacy records when accessible.

Flag gaps for pharmacist review—do not invent contraindications or give vaccine medical advice beyond your scope.

Document refusals factually ("Declines influenza vaccine this season—reason: fear of side effects") so the team can revisit.

Technician Script — Immunization Gap

Tech: "I don't see a shingles vaccine on file, and you're over 50. Have you completed the two-dose Shingrix series?" Patient: "I never got that." Tech: "I'll flag a possible immunization gap for the pharmacist. If it's appropriate, they can talk with you about getting it here or at your clinic."

Putting the History Together for the PMR / CMR Packet

A complete MTM history packet typically includes:

  • Demographics and contact preferences
  • Medication list (Rx, OTC, vitamins, herbals)
  • Allergies and intolerances with reaction details
  • Medical conditions
  • Social history
  • Immunizations
  • Relevant labs and monitoring when available (covered deeply in a later chapter)
  • Adherence barriers (from the prior section)
  • Mini Case Integration

Ms. R is preparing for a CMR. She takes apixaban, metformin, lisinopril, and atorvastatin. Condition list: AFib, T2DM, HTN, dyslipidemia. Social history: former smoker, drinks wine nightly. Immunizations: influenza this season on file; no zoster series documented.

Technician actions:

Expand abbreviations on the patient-facing PMR ("atrial fibrillation," "type 2 diabetes").

Note nightly alcohol for pharmacist review with anticoagulant and diabetes therapy.

Flag missing zoster series as a preventive gap.

Avoid diagnosing new disease or changing anticoagulants—collect and escalate.

Mastering these medical-history components makes your medication list interpretable. The pharmacist can then focus clinical judgment on indication, effectiveness, safety, and adherence—the heart of MTM—because you gathered the context that turns drugs into a coherent therapy story.